More than 400 pharmacies in Guangdong are cancelled and delisted, and there are development opportunities

Medical Network News on March 9 Since recent times, more than 400 pharmacies in Guangdong have cancelled and delisted
.

Number of pharmacies cancellation of delisting
According to incomplete statistics, since 2021, the Guangdong Province and Drug Administration issued a total of 13 cancellation of "drug business license," the announcement, the number of pharmacies has been canceled lawfully up to 410
.
The announcement showed that the main reason for the cancellation of these companies was "license expiration and invalidation" or "enterprise application
.
" In fact, this phenomenon does not only occur in Guangdong.
In the past two years, we have often seen announcements on the cancellation of the "Drug Business License" in various places
.
Since the second half of last year, Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi, Yunnan and other places have issued announcements on the cancellation of the "Drug Business License", and a large number of pharmacies have withdrawn from the market
.
The ultimate reason for pharmacies to withdraw from the market is the same-the problem of operating costs
.
Some pharmacies with weak operating capabilities, due to high cost pressures or over-saturation of the market, continue to increase operating pressures.
If they face the renewal deadline, it will be even worse, and they have chosen to give up due to cost and future development considerations
.
The survival pressure of pharmacies is so high mainly due to two reasons, market and policy
.
In fact, China's pharmacy market has become saturated
.
As early as 2018, the total number of pharmacies in the country reached 489,000, with an average of 2,854 people.
In the same period, there were 62,000 pharmacies in the United States, with an average number of people serving 6,250 people per store
.
According to the "Annual Report on Drug Supervision Statistics in 2019" issued by the State Drug Administration, the number of pharmacies in China has increased to 524,000 in 2019
.
In addition, due to the impact of the new crown pneumonia epidemic, online drug purchases are becoming more and more accepted by people, which has further changed people's consumption habits and brought a greater and substantial impact on the passenger flow of physical pharmacies.

.
According to the company's financial report, from the perspective of revenue scale, in 2019, JD Health will be on par with the four major chain pharmacies, and in 2020, it has surpassed the four major chain pharmacies
.
And the country's series of rectification policies are also not a small impact for small and medium pharmacies
.
For example, the previous crackdown on insurance fraud and strict inspections of licensed pharmacists, for small non-standard pharmacies, profits have fallen while operating costs have increased.
It can be said that it has entered a cold winter
.
In November 2020, the State Food and Drug Administration issued the "Notice on Regulating the Provision and Use of Licensed Pharmacists in Drug Retail Enterprises", stating that the verified "certified" licensed pharmacists will be entered into the national licensed pharmacist registration management information system, and their registration certificates will be revoked and To be exposed, "certified" licensed pharmacists must also be included in the credit management "blacklist", and multi-departmental joint disciplinary action will be implemented
.
Recently, the Shanxi Provincial Drug Administration also issued the "Notice on Printing and Distributing the Provincial Drug Circulation Supervision and Inspection Work Plan in 2021", which clearly stated that inspections should be carried out on the implementation of the "Pharmaceutical Business Quality Management Standards" by drug dealers in the province.
To “focus on investigating
and punishing the problems of “certification” of licensed pharmacists and off-duty performance of their duties .
Guangdong Province has also issued notices on the punishment of pharmacists’ registration in recent years
.


In addition, the licensed pharmacist policy and hierarchical management policy have a greater impact on the pharmacy industry
.
At the end of 2018, the Ministry of Commerce officially issued the "Guiding Opinions on the Classification and Classification Management of National Retail Pharmacies (Draft for Solicitation of Comments)" that by 2020, the classification and classification management system of retail pharmacies in most provinces and cities across the country will be basically established.
A unified regulatory and policy system for the classification and classification of retail pharmacies within the scope has been basically established
.
In the face of complex market conditions, as a group, single pharmacies will not perish, but as individuals, certain single pharmacies will inevitably be eliminated by the market because they cannot keep up with the pace of industry development
.


Pharmacies 　　with potential development opportunities disappeared.
On the one hand, they closed their doors and closed their businesses.
On the other hand, their exports were merged by large chain pharmacies.
In recent years, large chain pharmacies have expanded faster and faster.
A very important reason is the merger of small pharmacies
.
For the development of pharmacies, this is not a bad ending in essence.
Single pharmacies do not have enough market volume to negotiate cooperation with upstream industries.
The procurement cost is relatively high.
In addition, there are problems with the provision of professional pharmacists such as licensed pharmacists.
Neither marketing nor professional services can compete with large chains
.
The management of large chain pharmacies is more systematic, and the types of medicines backed by Dashu pharmacies can also be more enriched
.
In addition, there are quite a few policies that are good for pharmacies
.
For example, with the further advancement of the new medical reform policy, the policy of separating medicine will gradually be implemented
.
Taking volume purchase as an example, the promotion of centralized procurement is expected to accelerate the trend of prescription outflow, and the channel value of retail pharmacies has increased significantly, especially those manufacturers who have not won the bid to pay more attention to the pharmacy channel
.
Some gradual liberalization of the overall medical insurance settlement for chronic disease drugs in pharmacies means that more prescriptions will flow into pharmacies.
In the short term, the policy will have limited impact on the performance of pharmacies, while in the long run, pharmacies will accelerate with the outflow of prescriptions.
Its channel value will be re-understood
.
Pharmacies are an indispensable part of people’s daily lives.
From the perspective of the timeliness of medication, pharmacies that generally can meet patients’ medication timeliness to the greatest extent within 15 minutes if consumers are unable to do so, there is still considerable demand, but in the future The extent to which it develops depends on the efforts of the pharmacies
.
For example, many pharmacies provide users with health services and set up outpatient clinics
.
Medicines are different from other consumer products.
It is difficult to know exactly how to use symptomatic medications, medication methods, and medication contraindications.
According to research, 80% of patients need professional services and guidance
.
Each industry has a certain elimination rate.
Pharmacies are essentially a pure commercial system.
Faced with a complex market environment, pharmacies must change their minds if they want to survive
.